首頁 > 市場調查報告書 > 材料

酵素

市場調查報告書

商品編碼

1435374

2024 年酵素全球市場報告

Enzymes Global Market Report 2024

出版日期: 2024年02月23日 | 出版商:

The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

預計未來幾年酶市場規模將快速成長。預計到 2028 年將以 14.0% 的複合年成長率 (CAGR) 成長至 228.6 億美元。預計的成長將由不斷變化的市場需求、永續實踐、健康趨勢、生質燃料/可再生能源和新興應用推動。主要趨勢包括生物技術的進步、對永續性的重視、食品和飲料行業需求的增加、工業應用的擴大以及消費者對天然產品的偏好。

由於胃腸道疾病的盛行率日益增加，酵素市場預計將成長。這些影響消化器官系統的疾病包括胃食道逆流症 (GERD)、癌症、大腸激躁症(IBS)、乳糖不耐症、食道疝氣和膽結石等。消化酵素在將食物分解成可吸收分子方面發揮重要作用。截至2022年10月，美國生物技術資訊中心（NCBI）估計，美國大腸激躁症（IBS）的盛行率為10%至15%，近12%的患者患有IBS相關症狀。尋求治療。基層醫療實踐中的擔憂。胃腸道疾病的增加促進了酵素市場的成長。

癌症發生率的增加預計將加速酵素市場的發展，因此需要使用藥物代謝酶（DME）進行化療。這些酵素在體內被激活，可以消滅癌細胞並消滅腫瘤。癌症患者腫瘤組織和代謝器官中藥物代謝酶（DME）的表達和功能對於抗癌藥物和化療反應不佳的患者至關重要。美國癌症協會的《2022 年癌症事實和數字》報告估計，2022 年美國預計將新增 190 萬癌症病例，較 2020 年報告的 180 萬例有所增加。反映了這一成長。然而，預計 2022 年癌症死亡人數略高。預計死亡人數為 609,360 人，而 2021 年死亡人數為 608,570 人。治療用酵素治療的癌症盛行率不斷上升，預計將推動酵素市場的成長。

全球酵素市場，依產品類型細分、實際及預測，2018-2023、2023-2028、2033
Asparaginase
脂肪酶
蛋白酶
納豆激酶
幾丁質酶
鋸齒肽酶
膠原酶
連接酶
其他產品
全球酵素市場，按應用、性能和預測細分，2018-2023、2023-2028、2033
白血病
胃病
抗腫瘤
皮膚潰瘍
高雪氏症
法布瑞氏症
其他用途
全球酵素市場，按最終用戶細分，實際和預測，2018-2023、2023-2028、2033
製藥公司
醫院
私人診所
研究

第 7 章區域與國家分析

全球酵素市場，按地區、實際和預測，2018-2023、2023-2028、2033
全球酵素市場，依國家、表現及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章中國市場

第10章印度市場

第11章日本市場

第12章澳洲市場

第13章印尼市場

第14章韓國市場

第15章西歐市場

第16章英國市場

第17章德國市場

第18章法國市場

第19章義大利市場

第20章西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第25章加拿大市場

第26章南美洲市場

第27章巴西市場

第28章中東市場

第29章非洲市場

第30章競爭形勢及公司概況

酵素製劑市場競爭形勢
酵素市場公司概況
- BASF SE
- Hoffmann-La Roche AG
- Merck Sharp &Dohme LLC
- Sanofi SA
- Thermo Fisher Scientific Inc.

第31章其他大型創新公司

Associated British Foods plc
DuPont de Nemours Inc.
Kerry Group plc
Firmenich SA
Koninklijke DSM NV
Dyadic International Inc.
Novozymes A/S
Endo International plc
Chr Hansen Holding A/S
Advanced Enzyme Technologies Ltd.
Catalyst Pharmaceuticals Inc.
Codexis Inc.
AB Enzymes GmbH
Brain Biotech AG
Biocatalysts Ltd.

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章重大併購

第35章未來前景與可能性分析

第36章附錄

簡介目錄

Product Code: r15092

Enzymes are proteins that commonly function as biological catalysts, accelerating specific chemical reactions within cells without undergoing any alterations themselves.

Various enzyme product types include asparaginase, lipase, protease, nattokinase, chitinase, serratiopeptidase, collagenase, ligase, and others. Protease, for instance, catalyzes proteolysis, breaking down proteins into smaller polypeptides or individual amino acids while facilitating the creation of new protein products. These enzymes find application in treating conditions such as leukemia, stomach disorders, antitumor therapies, skin ulcers, Gaucher disease, Fabry disease, among others. They are utilized by drug manufacturers, hospitals, private clinics, and research laboratories.

The enzymes market research report is one of a series of new reports from The Business Research Company that provides enzymes market statistics, including enzymes industry global market size, regional shares, competitors with an enzymes market share, detailed enzymes market segments, market trends, and opportunities, and any further data you may need to thrive in the enzymes industry. This enzymes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The enzymes market size has grown rapidly in recent years. It will grow from $11.78 billion in 2023 to $13.52 billion in 2024 at a compound annual growth rate (CAGR) of 14.8%. The growth observed in the historical period can be attributed to several factors, including globalization fostering market expansion, increased investments in research and development, growing consumer awareness and demand, advancements in bioprocessing technology, and a focus on waste reduction and recycling initiatives.

The enzymes market size is expected to see rapid growth in the next few years. It will grow to $22.86 billion in 2028 at a compound annual growth rate (CAGR) of 14.0%. Forecasted growth is driven by market demand shifts, sustainable practices focus, health trends, biofuel/renewable energy, and emerging applications. Major trends include biotech advancements, sustainability emphasis, increased demand in food/beverage industries, industrial application expansion, and consumer preference for natural products.

The enzyme market is anticipated to experience growth driven by an increase in the prevalence of digestive disorders. These disorders, impacting the digestive system, encompass conditions such as gastroesophageal reflux disease (GERD), cancer, irritable bowel syndrome (IBS), lactose intolerance, hiatal hernia, and gallstones. Digestive enzymes play a crucial role in breaking down food into absorbable molecules. As of October 2022, the National Center for Biotechnology Information (NCBI) reports that the prevalence of irritable bowel syndrome (IBS) in the United States ranges between 10% and 15%, with nearly 12% of patients seeking medical care for IBS-related concerns in primary care practices. This rise in digestive disorders contributes to the growth of the enzyme market.

The enzyme market is expected to be fueled by the increasing prevalence of cancer, necessitating the use of drug-metabolizing enzymes (DMEs) for chemotherapy. These enzymes activate within the body to destroy cancer cells and break down tumors. The expression and functionality of drug-metabolizing enzymes (DMEs) in the tumor tissues and metabolic organs of cancer patients are crucial for those with a low response to anticancer drugs and chemotherapy. The Cancer Facts and Figures 2022 report by the American Cancer Society indicates an estimated 1.9 million new cancer cases in the United States in 2022, reflecting an increase from the 1.8 million reported in 2020. While the estimated number of cancer deaths in 2022 is slightly higher than in 2021, with 609,360 projected deaths compared to 608,570 in 2021. The rising prevalence of cancer treatable with therapeutic enzymes is anticipated to propel the growth of the enzyme market.

Leading companies in the enzyme market are focusing on innovation by developing advanced products such as Lamzede, catering to the needs of patients. Lamzede (velmanase alfa) is a pharmaceutical product designed for the treatment of alpha-mannosidosis, a rare genetic disorder characterized by insufficient activity of the lysosomal alpha-galactosidase-A enzyme. In a noteworthy development in May 2023, Chiesi Global Rare Diseases, a pharmaceutical manufacturing company based in the United States, obtained FDA approval for Lamzede (velmanase alfa). This approval pertains to the treatment of non-neurological symptoms in patients with mild-to-moderate alpha-mannosidosis. Lamzede represents a recombinant form of human alpha-mannosidase, developed using recombinant DNA technology in mammalian Chinese hamster ovary (CHO) cells. It stands out as the first enzyme replacement therapy sanctioned in the U.S. for addressing the non-central nervous system manifestations of alpha-mannosidosis.

A notable trend gaining prominence in the enzymes market is the exploration of novel approaches for cancer treatment utilizing enzymes. Substantial investments in research by major universities and companies aim to advance enzyme therapies for combating cancer. In another significant development in May 2023, Chiesi Global Rare Diseases secured FDA approval for ELFABRIO (pegunigalsidase alfa-iwxj), designed to address Fabry disease. This rare genetic disorder is characterized by insufficient activity of the lysosomal a-galactosidase-A enzyme, leading to the progressive accumulation of globotriaosylceramide (Gb3) in blood vessel walls throughout the body. ELFABRIO (pegunigalsidase alfa-iwxj) stands out as a PEGylated enzyme replacement therapy (ERT).

In February 2023, AstraZeneca, a U.S.-based pharmaceutical company, completed the acquisition of CinCor Pharma Inc. for $1.3 billion. This strategic move is set to strengthen AstraZeneca's cardiorenal pipeline through the incorporation of CinCor's candidate drug, baxdrostat (CIN-107). Baxdrostat is an aldosterone synthase inhibitor (ASI) designed for lowering blood pressure in individuals with treatment-resistant hypertension. CinCor Pharma Inc., the acquired biotechnology company, is based in the United States and is focused on the development of enzyme-based therapeutics.

Major companies operating in the enzymes market report are Ramboll Group A/S, Jacobs Engineering Group Inc., AECOM Technical Services Inc., ERM Group Limited, WSP Global Inc., SNC-Lavalin Group Inc., Wood PLC, Stantec Inc., Black & Veatch Corporation, Tetra Tech Inc., Arcadis NV, Mott MacDonald Group Ltd., GHD Group Limited, TRC Companies Inc., Form Technologies Inc., Golder Associates Ltd., Cardno Limited, CH2M HILL Engineers Inc., SLR Consulting Ltd., Weston Solutions Inc., IndustrySafe Inc., ECS Limited, Geosyntec Consultants LLC, Apex Companies Inc., GZA GeoEnvironmental Technologies Inc., Haley & Aldrich Inc., Intelex Corporation, iAuditor Inc., Metrix Software Solutions Inc., Lighthouse Systems Inc., SafetyTek Inc., Strategix Application Solutions LLC, Effivity Technologies LLC, SiteDocs Inc., SafetySync LLC, Qooling Systems Inc.

North America was the largest region in the enzymes market in 2023. The regions covered in the enzymes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the enzymes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The enzyme market consists of sales of oxidoreductases, transferases, and hydrolases. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Enzymes Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on enzymes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for enzymes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The enzymes market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Product Type: Asparaginase; Lipase; Protease; Nattokinase; Chitinase; Serratiopeptidase; Collagenase; Ligase; Other Products
2) By Application: Leukemia; Stomach Disorders; Antitumor; Skin Ulcers; Gaucher Disease; Fabry Disease; Other Applications
3) By End User: Drug Manufacturers; Hospitals; Private Clinics; Research Laboratories
Companies Mentioned: Ramboll Group A/S; Jacobs Engineering Group Inc.; AECOM Technical Services Inc.; ERM Group Limited; WSP Global Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. Enzymes Market Characteristics

3. Enzymes Market Trends And Strategies

4. Enzymes Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Enzymes Market Size and Growth

5.1. Global Enzymes Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Enzymes Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Enzymes Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Enzymes Market Segmentation

6.1. Global Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Asparaginase
Lipase
Protease
Nattokinase
Chitinase
Serratiopeptidase
Collagenase
Ligase
Other Products
6.2. Global Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Leukemia
Stomach Disorders
Antitumor
Skin Ulcers
Gaucher Disease
Fabry Disease
Other Applications
6.3. Global Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Drug Manufacturers
Hospitals
Private Clinics
Research Laboratories

7. Enzymes Market Regional And Country Analysis

7.1. Global Enzymes Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Enzymes Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Enzymes Market

8.1. Asia-Pacific Enzymes Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Enzymes Market

9.1. China Enzymes Market Overview
9.2. China Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Enzymes Market

10.1. India Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Enzymes Market

11.1. Japan Enzymes Market Overview
11.2. Japan Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Enzymes Market

12.1. Australia Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Enzymes Market

13.1. Indonesia Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Enzymes Market

14.1. South Korea Enzymes Market Overview
14.2. South Korea Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Enzymes Market

15.1. Western Europe Enzymes Market Overview
15.2. Western Europe Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Enzymes Market

16.1. UK Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Enzymes Market

17.1. Germany Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Enzymes Market

18.1. France Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Enzymes Market

19.1. Italy Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Enzymes Market

20.1. Spain Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Enzymes Market

21.1. Eastern Europe Enzymes Market Overview
21.2. Eastern Europe Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Enzymes Market

22.1. Russia Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Enzymes Market

23.1. North America Enzymes Market Overview
23.2. North America Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Enzymes Market

24.1. USA Enzymes Market Overview
24.2. USA Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Enzymes Market

25.1. Canada Enzymes Market Overview
25.2. Canada Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Enzymes Market

26.1. South America Enzymes Market Overview
26.2. South America Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Enzymes Market

27.1. Brazil Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Enzymes Market

28.1. Middle East Enzymes Market Overview
28.2. Middle East Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Enzymes Market

29.1. Africa Enzymes Market Overview
29.2. Africa Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Enzymes Market Competitive Landscape And Company Profiles

30.1. Enzymes Market Competitive Landscape
30.2. Enzymes Market Company Profiles
- 30.2.1. BASF SE
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Hoffmann-La Roche AG
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Merck Sharp & Dohme LLC
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Sanofi SA
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Thermo Fisher Scientific Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Enzymes Market Other Major And Innovative Companies

31.1. Associated British Foods plc
31.2. DuPont de Nemours Inc.
31.3. Kerry Group plc
31.4. Firmenich SA
31.5. Koninklijke DSM NV
31.6. Dyadic International Inc.
31.7. Novozymes A/S
31.8. Endo International plc
31.9. Chr Hansen Holding A/S
31.10. Advanced Enzyme Technologies Ltd.
31.11. Catalyst Pharmaceuticals Inc.
31.12. Codexis Inc.
31.13. AB Enzymes GmbH
31.14. Brain Biotech AG
31.15. Biocatalysts Ltd.

32. Global Enzymes Market Competitive Benchmarking

33. Global Enzymes Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Enzymes Market

35. Enzymes Market Future Outlook and Potential Analysis

35.1 Enzymes Market In 2028 - Countries Offering Most New Opportunities
35.2 Enzymes Market In 2028 - Segments Offering Most New Opportunities
35.3 Enzymes Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies